CTI BIOPHARMA CORP

CUSIP: 12648L601 Class: Common Stock

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 1,932,153 Value ($000) $8,115 Avg Close — Range —
Q4 2022
Shares 1,455,589 Value ($000) $8,748 Avg Close — Range —
Q3 2022
Shares 1,241,311 Value ($000) $7,224 Avg Close — Range —
Q2 2022
Shares 1,284,325 Value ($000) $7,667 Avg Close — Range —
Q1 2022
Shares 995,280 Value ($000) $4,648 Avg Close — Range —
Q4 2021
Shares 1,145,280 Value ($000) $2,840 Avg Close — Range —
Q3 2021
Shares 1,136,049 Value ($000) $3,351 Avg Close — Range —
Q2 2021
Shares 978,679 Value ($000) $2,447 Avg Close — Range —
Q1 2021
Shares 1,111,680 Value ($000) $3,235 Avg Close — Range —
Q4 2020
Shares 989,602 Value ($000) $3,187 Avg Close — Range —
Q3 2020
Shares 770,731 Value ($000) $1,657 Avg Close — Range —
Q1 2018
Shares 11,233 Value ($000) $44 Avg Close — Range —